- $46.16m
- -$41.88m
- $0.10m
Brief: Ibio Inc - On Track For Regulatory Submission For Ibio-600 In Q1 2026
Brief: Ibio And Astralbio Provide Update On Myostatin Program For Obesity
Brief: Ibio Appoints Kristi Sarno As Senior Vice President Of Business Development
Brief: Ibio Inc Says Entered Into Purchase, Sale Agreement, Dated As Of May 17, With Board Of Regents Of Texas A&M University System